CooperSurgical unveils new inserter for simplified Paragard IUD placement
September 4th 2024The new single-handed inserter by CooperSurgical streamlines the placement of Paragard, a hormone-free IUD with over 30 years of proven efficacy, enhancing accessibility for both health care providers and patients.
Read More
How AI can improve antenatal estimation of gestational age
August 13th 2024In a recent study, the accuracy of an artificial intelligence tool operated by novice users with no prior ultrasonography training for estimating gestational age was similar to that of expert sonographers conducting standard biometry.
Read More
How the mifepristone case highlights the need to protect reproductive health care
August 13th 2024Following the Supreme Court’s decision to retain mifepristone access in June 2024, health care providers have spoken out about the need to fight for reproductive health care protections on a national and local level.
Read More
Reduced physical function linked to fracture risk in older women with T2D
August 12th 2024In a recent study, older women with type 2 diabetes had a higher bone mineral density but reduced physical function, linking the reduction in physical function to increased fracture risk in this population.
Read More
Higher multimorbidity risk reported from reduced reproductive lifespan
August 12th 2024A recent study found that women with a shorter reproductive lifespan had increased odds of multimorbidity compared to those with a longer reproductive lifespan, indicating a need to assess reproductive factors to determine high-risk patients.
Read More
Link found between delayed prenatal care and congenital syphilis rates
August 7th 2024A study presented at the Infectious Disease Society for Obstetrics and Gynecology 2024 Annual Meeting found an increase of 4 days between diagnosis and treatment among pregnant patients with congenital syphilis vs those without congenital syphilis.
Read More
Reducing costs and increasing accessibility key to enhancing STI testing among youth
August 6th 2024A study presented at the Infectious Disease Society for Obstetrics and Gynecology 2024 Annual Meeting highlights the importance of affordability and convenience in boosting STI test uptake among adolescents and young adults.
Read More
Discussing low-dose aspirin use for preeclampsia prevention
August 5th 2024A study discussed by Tabby Khan, MD. MPH, reveals low rates of low-dose aspirin use among high-risk preeclampsia patients, highlighting the need for increased clinician awareness and better insurance coverage to improve maternal and infant health outcomes.
Read More
Low-dose aspirin prescription rate low among high-risk preeclampsia patients
August 1st 2024Despite guidelines, a study reveals a significant gap in the prescription of low-dose aspirin to pregnant women at high risk of preeclampsia, highlighting an urgent need for improved adherence and monitoring.
Read More
Bayer submits NDA for elinzanetant to treat vasomotor symptoms
Published: August 1st 2024 | Updated: August 1st 2024Bayer has submitted a New Drug Application for elinzanetant, following positive results from the OASIS studies, showing significant safety and efficacy in treating moderate-to-severe vasomotor symptoms in menopausal women.
Read More